Rise Nano Optics to Present at Planet MicroCap Toronto 2026

Vancouver, BC – October 26, 2026 — Rise Nano Optics Ltd. (CSE: EYE) (OTCQB: RNOLF) (FSE: U9Y) (“Rise” or the “Company”), a health technology company advancing vision care through patented nanotechn...

Rise Nano Optics Announces Proposed Non-Brokered Private Placement of Up to C$5 Million

Financing intended to accelerate SpectraGuard™ commercialization, expand optical industry partnerships and support manufacturing growth Recent Highlights: ·       FDA Registration: Rise successful...

Rise Nano Optics to Attend the 2026 Cantech Investment Conference in Toronto

Vancouver, BC– October 1, 2026 — Rise Nano Optics Ltd. (CSE: EYE)(OTCQB: RNOLF)(FSE: U9Y)(“Rise” or the “Company”), a health technology company advancing vision care through patented nanotechnology...

Rise Nano Optics to Sponsor INVISION MATCH! 2026, Connecting SpectraGuard with Leading Independent Eye Care Practices

Company to participate in curated one-on-one meetings with leading independent optometry practice owners as it expands U.S. commercialization of SpectraGuard™   Vancouver, British Columbia – Septem...

Rise Nano Optics to Attend the Vision Council’s 2026 Lab Leadership Forum

Sold-out industry forum brings together leaders from the independent optical laboratory sector as Rise advances its lab-first commercialization strategy for SpectraGuard™   Vancouver, BC– September...

Rise Nano Optics Joins the Vision Council, a Leading Optical Trade Association, Expanding Access to Key Optical Relationship

Membership provides access to hundreds of optical manufacturers, laboratories, retailers and industry stakeholders as Rise accelerates North American commercialization of its patented SPECTRAGUARD™...

Rise Nano Optics Announces Frankfurt Stock Exchange Listing

Expanding European investor access and global visibility for patented SPECTRAGUARD™ technology Vancouver, British Columbia – August 10, 2026 – Rise Nano Optics Ltd. (“Rise” or the “Company”) (CSE: ...

Rise Nano Optics Ltd. Announces AGSM Results

Vancouver, British Columbia – August 6, 2026 – Rise Nano Optics Ltd. (CSE: EYE) (OTCQB: RNOLF) (“Rise” or the “Company“), is pleased to announce that all resolutions were passed at the annual gener...

Rise Nano Optics Uplists to OTCQB Venture Market and Achieves DTC Eligibility, Expanding Access to U.S. Investors

Commenced Trading on the OTCQB Under the Symbol “RNOLF” While Continuing to Trade on the CSE Under the Symbol “EYE” Vancouver, British Columbia – August 3, 2026 — Rise Nano Optics Ltd. (“Rise” o...

Rise Nano Optics Announces First U.S. Eye Care Professional Partnership with LI Opticians

First Clinical Channel Partnership in the United States as Part of the Company’s Phased Commercialization Strategy Vancouver, British Columbia – July 9, 2026 — Rise Nano Optics Ltd. (“Rise” or t...

Rise Nano Optics Announces Strategic Partnership with SportifEye Optics to Produce and Commercialize SpectraGuard™ Lenses in the United States

Expanding Lab Partnership Network now includes expertise in Sport, Safety and Performance Eyewear. Vancouver, British Columbia – June 24th , 2026 — Rise Nano Optics Ltd. (“Rise” or the “Company”...

Rise Nano Optics Announces Strategic Partnership with Sierra Optical Lab to Produce and Commercialize SpectraGuard™ Lenses in the United States

Significant Milestone in Defined North American Commercialization Strategy   Vancouver, British Columbia – April 20th, 2026 — Rise Nano Optics Ltd. (“Rise” or the “Company”) (CSE: EYE), a health te...

Rise Nano Optics Announces FDA Class I Device Classification for SPECTRAGUARD™ Nano-Optic Lens Technology

Proprietary, patented technology providing vision protection beyond UV and Blue Light Vancouver, British Columbia, March 23, 2026 – Rise Nano Optics Ltd. (“Rise” or the “Company”) (CSE: EYE) a heal...

Rise Nano Optics Appoints Erik Ritchie as Chief Commercial Officer to Lead North American Commercialization Strategy

Vancouver, British Columbia, March 17, 2026 – Rise Nano Optics Ltd. (“Rise” or the “Company”) (CSE: EYE) a health technology company advancing vision care through patented nanotechnology lens solut...

Rise Nano Optics to Commence Trading on the Canadian Securities Exchange Under the Symbol “EYE”, Today, March 12, 2026

Vancouver, British Columbia, March 12, 2026 – Rise Nano Optics Ltd. (“Rise” or the “Company”) (CSE: EYE) is pleased to announce that it has received approval to list its common shares (the “Common ...

Rise Nano Optics Receives Final Receipt for Prospectus and Closes RTO Transaction

Vancouver, British Columbia (March 4, 2026) – Rise Nano Optics Ltd. (formerly Skylift Tech Ventures Ltd.) (“Rise” or the “Company”) is pleased to announce that it has obtained a final receipt for i...

Rise Health Nano Optics Granted Third U.S. Patent for Breakthrough Nano-Optic Technology Advancing Preventative Vision Care

Vancouver, Canada – November 4, 2025 – Rise Health Nano Optics Inc. (“Rise” or the “Company”), a health technology innovator specializing in nano-optic solutions that effectively block wavelengths ...

Rise Health Nano Optics Achieves FDA Clearance Milestone Following Successful Biocompatibility Testing for EYEGUARD™ Lenses

Vancouver, Canada – Rise Health Nano Optics Inc. (“Rise” or the “Company”), a health-tech innovator specializing in advanced, preventative optical solutions, is pleased to announce a major mileston...

Rise Nano Optics Announces Breakthrough in Nanomaterials Driving Major Production Efficiency Gains

Doubles Production Capacity in 7- Hour Cycle, Enabling Efficient, Global Scale Potential Rise Nano Optics Inc. (“Rise” or the “Company”), a health-technology innovator specializing in nano-optic so...

Rise Health Nano Optics Provides Corporate Update on FDA Approval Process and Product Development Milestones

Rise Health Nano Optics Inc. (“Rise” or the “Company”), a health-tech innovator specializing in advanced, preventative optical solutions, is pleased to provide a corporate update highlighting pro...